BC Platforms

About:

BC Platforms is a data and technology company providing tools to advance the development of personalized medicine and precision medicine.

Website: http://www.bcplatforms.com

Twitter/X: BCPlatforms

Top Investors: IQVIA, Tesi, Jolt Capital, Boston Millennia Partners, Debiopharm Innovation Fund

Description:

BCP provides a unique data and technology platform to enable life sciences and healthcare companies to access, manage and analyze clinical and omics data. BCP’s Data Access Platform provides access and related technology to valuable data (RWD, Clinical, Genomics, and Omics) for the Life Science Industry. The Company’s Data Partner Network currently covers more than 22m life-years of highly curated patient data from around the world and is steadily growing. These data are made accessible to Pharma companies through a data-as-a-service (DaaS) model. BCP is able to provide Life Science companies with transformational capabilities to access longitudinal clinical and genome data across the globe to enhance different use cases within the R&D continuum, speeding up the process from early discovery to clinical and post-market access processes. BCP’s technology platform provides technology to Healthcare Providers and Life Science companies to produce, manage and analyze complex genomics as a clinical decision-support solution, analyze the data (genomics- omics and clinical) and make it available for any research ensuring compatibility with all relevant technical standards and in compliance with local privacy law in different jurisdictions.

Total Funding Amount:

$45.3M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Zürich, Zurich, Switzerland

Founded Date:

1997-01-01

Contact Email:

customerservice(AT)bcplatforms.com

Founders:

Timo Kanninen

Number of Employees:

101-250

Last Funding Date:

2022-11-08

IPO Status:

Private

Industries:

© 2025 bioDAO.ai